1. Lymphatic targeting of nanosystems for anticancer drug therapy;Abellan-Pose;Curr. Pharm. Des.,2015
2. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy;Aggarwal;Adv. Drug Deliv. Rev.,2009
3. Alonso M.J., Torres D., Rivera-Rodríguez G.R., Oyarzun-Ampuero F.A., Lollo G., Gonzalo T., Garcia-Fuentes M., 2012. Patent WO2012095543 A1—Nanocapsules with a polymer shell.
4. Alonso-Nocelo, M., Abellan-Pose, R., Vidal, A., Abal, M., Csaba, N., Alonso, M., Lopez-Lopez, R., de la Fuente, M., n.d. Selective interaction of PEGylated Polyglutamic Acid nanocapsules with cancer cells in a 3D model of a metastatic lymph node. Submitt. to J. Nanobiotechnology.
5. Polyester nanocapsules as new topical ocular delivery systems for cyclosporin a;Calvo;Pharm. Res.,1996